Letter by Ye and Zhang regarding article, "Bayesian methods affirm the use of percutaneous coronary intervention to improve survival in patients with unprotected left main coronary artery disease".
作者信息
Ye Yicong, Zhang Shuyang
机构信息
Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.
出版信息
Circulation. 2014 Jan 28;129(4):e307. doi: 10.1161/CIRCULATIONAHA.113.004523.
Abstract
摘要
相似文献
1
Letter by Ye and Zhang regarding article, "Bayesian methods affirm the use of percutaneous coronary intervention to improve survival in patients with unprotected left main coronary artery disease".叶和张就文章《贝叶斯方法证实经皮冠状动脉介入治疗可提高无保护左主干冠状动脉疾病患者的生存率》所写的信件。
Circulation. 2014 Jan 28;129(4):e307. doi: 10.1161/CIRCULATIONAHA.113.004523.
2
Letter by Diamond regarding article, "Bayesian methods affirm the use of percutaneous coronary intervention to improve survival in patients with unprotected left main coronary artery disease".戴蒙德就“贝叶斯方法支持使用经皮冠状动脉介入治疗改善无保护左主干冠状动脉疾病患者生存率”一文所写的信。
Circulation. 2014 Jan 28;129(4):e308. doi: 10.1161/CIRCULATIONAHA.113.004321.
3
Response to letters regarding article, "Bayesian methods affirm the use of percutaneous coronary intervention to improve survival in patients with unprotected left main coronary artery disease".对关于文章《贝叶斯方法支持使用经皮冠状动脉介入治疗改善无保护左主干冠状动脉疾病患者生存率》的信件的回复
Circulation. 2014 Jan 28;129(4):e309. doi: 10.1161/CIRCULATIONAHA.113.007266.
4
Bayesian methods affirm the use of percutaneous coronary intervention to improve survival in patients with unprotected left main coronary artery disease.贝叶斯方法肯定了经皮冠状动脉介入治疗在改善无保护左主干冠状动脉疾病患者生存方面的应用。
Circulation. 2013 Jun 4;127(22):2177-85. doi: 10.1161/CIRCULATIONAHA.112.000646. Epub 2013 May 14.
5
Differential Event Rates and Independent Predictors of Long-Term Major Cardiovascular Events and Death in 5795 Patients With Unprotected Left Main Coronary Artery Disease Treated With Stents, Bypass Surgery, or Medication: Insights From a Large International Multicenter Registry.5795例接受支架植入、搭桥手术或药物治疗的无保护左主干冠状动脉疾病患者的长期主要心血管事件和死亡的差异事件发生率及独立预测因素：来自大型国际多中心注册研究的见解
Circ Cardiovasc Interv. 2017 Jul;10(7). doi: 10.1161/CIRCINTERVENTIONS.116.004988.
6
Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.多支血管病变和/或无保护左主干病变患者行冠状动脉支架置入术或旁路移植术的个体长期死亡率预测：SYNTAX II 评分模型在 BEST 和 PRECOMBAT 随机对照试验 1480 例患者中的外部验证。
JACC Cardiovasc Interv. 2016 Aug 8;9(15):1564-72. doi: 10.1016/j.jcin.2016.04.023.
7
Percutaneous Coronary Intervention of Left Main Disease: Pre- and Post-EXCEL (Evaluation of XIENCE Everolimus Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) and NOBLE (Nordic-Baltic-British Left Main Revascularization Study) Era.左主干疾病的经皮冠状动脉介入治疗：EXCEL（评价依维莫司洗脱支架 XIENCE 与冠状动脉旁路移植术治疗左主干血运重建效果）和 NOBLE（北欧-波罗的海-英国左主干血运重建研究）时代之前和之后。
Circ Cardiovasc Interv. 2017 Jun;10(6). doi: 10.1161/CIRCINTERVENTIONS.117.004792.
8
Percutaneous coronary intervention or coronary artery bypass grafting for unprotected left main coronary artery disease.经皮冠状动脉介入治疗或冠状动脉旁路移植术治疗无保护左主干冠状动脉疾病。
Catheter Cardiovasc Interv. 2017 Oct 1;90(4):541-552. doi: 10.1002/ccd.26970. Epub 2017 Mar 15.
9
Bayesian methods for evidence evaluation: are we there yet?
Circulation. 2013 Jun 18;127(24):2367-9. doi: 10.1161/CIRCULATIONAHA.113.003193. Epub 2013 May 14.
10
Left Main Stenting in Comparison With Surgical Revascularization: 10-Year Outcomes of the (Left Main Coronary Artery Stenting) LE MANS Trial.左主干支架置入术与外科血运重建术的比较：（左主干冠状动脉支架置入术）勒芒试验的10年结果
JACC Cardiovasc Interv. 2016 Feb 22;9(4):318-327. doi: 10.1016/j.jcin.2015.10.044.
Zotero 插件